Accelerating clinical development through digital health technologies

Digital health technologies provide a roadmap for modernising clinical trials 

The future of patient-centred research is digital, as wearables, connected medical devices, and mobile apps reshape how trials collect data. These digital healthcare technologies offer richer insights, reduce patient burden, and help sponsors meet rising regulatory expectations, including FDA digital health technology guidance. 

This whitepaper presents a comprehensive roadmap for adopting digital health technologies (DHTs) in clinical trials, from selecting the right wearable sensors and digital measures to implementing them at scale. It introduces the V3 Framework for verifying, validating, and clinically confirming digital measures and digital endpoints, and highlights the proven ROI of DHT-enabled studies. 

Read the whitepaper to learn: 

• What DHTs are and how they transform evidence generation
• The difference between digital biomarkers and digital endpoints
• How to apply the V3 Framework for regulatory-ready validation
• Strategies to reduce trial costs and accelerate timelines